The Centers for Disease Control and Prevention has updated its interim guidance for health care professionals for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection. The guidance includes criteria for who should be evaluated for MERS-CoV, which have been updated to include individuals with fever and pneumonia or acute respiratory distress syndrome who have a history of being in a health care facility as a patient, worker or visitor in South Korea within 14 days of symptom onset. The guidance also contains guidelines for the evaluation and management of close contacts, as well as reporting, laboratory testing and infection control. CDC said it will update the infection control guidance in the coming days. MERS-CoV, which can be fatal, was first reported in Saudi Arabia in 2012 and has since spread to several other countries, including South Korea, where an outbreak was first reported in May. For more, including common signs and symptoms, see the CDC’s MERS webpage

Related News Articles

News
The AHA April 29 urged majority and minority leaders in both the Senate and House to not make disruptive policy changes to Medicaid and other coverage options…
Headline
The Supreme Court April 29 ruled 7-2 in favor of the Department of Health and Human Services in a case that challenged how HHS applied Congress’ formula for…
Headline
The House Energy and Commerce Committee held a markup April 29 where it advanced the AHA-supported SUPPORT Act (H.R. 2483). The legislation would reauthorize…
Headline
The AHA May 5 will award Mary Beth Kingston, Ph.D., its 2025 Award of Honor during the AHA Annual Membership Meeting in Washington, D.C. Kingston, an outspoken…
Blog
Public
In today’s rapidly evolving health care landscape — where patient outcomes and safety are non-negotiable top priorities — health systems and their staff are…
Headline
During the 2025 AHA Annual Membership Meeting in Washington, D.C., the AHA will present Melinda Estes, M.D., former president and CEO of Saint Luke's Health…